Aflibercept (Eylea) Market: Strategic Shifts Post-Patent Expiry And Biosimilar Impact
- Published: Sep, 2025
- Report ID: GVR-MT-100431
- Format: PDF/Excel databook
- No. of Pages/Datapoints: 120
- Report Coverage: 2024 - 2030
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Aflibercept (Eylea) Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Pricing Analysis
Chapter 4. Aflibercept (Eylea) Market: Indication Business Analysis
4.1. Indication Market Share, 2024 & 2033
4.2. Indication Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Indication, 2021 to 2033 (USD Million)
4.4. Wet Age-Related Macular Degeneration (AMD)
4.4.1. Wet Age-Related Macular Degeneration (AMD) Market, 2021 - 2033 (USD Million)
4.5. Diabetic Macular Edema (DME)
4.5.1. Diabetic Macular Edema (DME) Market, 2021 - 2033 (USD Million)
4.6. Diabetic Retinopathy without DME (DR)
4.6.1. Diabetic Retinopathy without DME (DR) Market, 2021 - 2033 (USD Million)
4.7. Others
4.7.1. Others Market, 2021 - 2033 (USD Million)
Chapter 5. Aflibercept (Eylea) Market: Formulation Business Analysis
5.1. Formulation Market Share, 2024 & 2033
5.2. Formulation Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Formulation, 2021 to 2033 (USD Million)
5.4. Eylea 2 mg
5.4.1. Eylea 2 mg Market, 2021 - 2033 (USD Million)
5.5. Eylea HD 8 mg
5.5.1. Eylea HD 8 mg, 2021 - 2033 (USD Million)
Chapter 6. Aflibercept (Eylea) Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2033
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
6.4. North America
6.5. Europe
6.6. Asia Pacific
6.7. Latin America
6.8. Middle East and Africa
Chapter 7. Competitive Landscape
7.1. Company Profile
7.1.1. Regeneron Pharmaceuticals, Inc.
7.1.1.1. Overview
7.1.1.2. Financial Performance
7.1.1.3. Strategic Mapping
7.1.2. Bayer AG
7.1.2.1. Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Mapping
7.2. Concurrent Competitive Landscape
7.2.1. Amgen
7.2.1.1. Overview
7.2.1.2. Financial Performance
7.2.1.3. Product Benchmarking
7.2.1.4. Strategic Mapping
7.2.2. Sandoz
7.2.2.1. Overview
7.2.2.2. Financial Performance
7.2.2.3. Product Benchmarking
7.2.2.4. Strategic Mapping
7.2.3. Biocon
7.2.3.1. Overview
7.2.3.2. Financial Performance
7.2.3.3. Product Benchmarking
7.2.3.4. Strategic Mapping
7.2.4. Samsung Bioepis
7.2.4.1. Overview
7.2.4.2. Financial Performance
7.2.4.3. Product Benchmarking
7.2.4.4. Strategic Mapping
7.2.5. Celltrion
7.2.5.1. Overview
7.2.5.2. Financial Performance
7.2.5.3. Product Benchmarking
7.2.5.4. Strategic Mapping
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Aflibercept (Eylea) market, by region, 2021 - 2033 (USD Million)
Table 4 North America Aflibercept (Eylea) market, by Indication, 2021 - 2033 (USD Million)
Table 5 North America Aflibercept (Eylea) market, by Formulation, 2021 - 2033 (USD Million)
Table 6 Europe Aflibercept (Eylea) market, by Indication, 2021 - 2033 (USD Million)
Table 7 Europe Aflibercept (Eylea) market, by Formulation, 2021 - 2033 (USD Million)
Table 8 Asia Pacific Aflibercept (Eylea) market, by Indication, 2021 - 2033 (USD Million)
Table 9 Asia Pacific Aflibercept (Eylea) market, by Formulation, 2021 - 2033 (USD Million)
Table 10 Latin America Aflibercept (Eylea) market, by Indication, 2021 - 2033 (USD Million)
Table 11 Latin America Aflibercept (Eylea) market, by Formulation, 2021 - 2033 (USD Million)
Table 12 Middle East & Africa Aflibercept (Eylea) market, by Indication, 2021 - 2033 (USD Million)
Table 13 Middle East Aflibercept (Eylea) market, by Formulation, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Aflibercept (Eylea) market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Indication outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Aflibercept (Eylea) market dynamics
Fig. 12 Aflibercept (Eylea) market: Porter’s five forces analysis
Fig. 13 Aflibercept (Eylea) market: PESTLE analysis
Fig. 14 Indication market, 2021 - 2033 (USD Million)
Fig. 15 Wet Age-Related Macular Degeneration (AMD) market, 2021 - 2033 (USD Million)
Fig. 16 Diabetic Macular Edema (DME) market, 2021 - 2033 (USD Million)
Fig. 17 Diabetic Retinopathy without DME (DR) market, 2021 - 2033 (USD Million)
Fig. 18 Others market, 2021 - 2033 (USD Million)
Fig. 19 Formulation market, 2021 - 2033 (USD Million)
Fig. 20 Eylea 2 mg market, 2021 - 2033 (USD Million)
Fig. 21 Eylea HD 8 mg market, 2021 - 2033 (USD Million)
Fig. 22 Aflibercept (Eylea) market revenue, by region
Fig. 23 Regional marketplace: Key takeaways
Fig. 24 North America Aflibercept (Eylea) market, 2021 - 2033 (USD Million)
Fig. 25 Europe Aflibercept (Eylea) market, 2021 - 2033 (USD Million)
Fig. 26 Asia Pacific Aflibercept (Eylea) market, 2021 - 2033 (USD Million)
Fig. 27 Latin America Aflibercept (Eylea) market, 2021 - 2033 (USD Million)
Fig. 28 MEA Aflibercept (Eylea) market, 2021 - 2033 (USD Million)
Fig. 29 Company categorization
Fig. 30 Company market position analysis
Fig. 31 Strategic framework
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.